Literature DB >> 17312116

Virus-specific CD8+ T cells in the liver: armed and ready to kill.

Rachael Keating1, Wen Yue, John A Rutigliano, Jenny So, Elvia Olivas, Paul G Thomas, Peter C Doherty.   

Abstract

Influenza A virus infection of C57BL/6 mice is a well-characterized model for studying CD8+ T cell-mediated immunity. Analysis of primary and secondary responses showed that the liver is highly enriched for CD8+ T cells specific for the immunodominant H2D(b)NP(366-374) (D(b)NP(366)) epitope. Functional analysis established that these liver-derived virus-specific CD8+ T cells are fully competent cytotoxic effectors and IFN-gamma secretors. In addition, flow cytometric analysis of early apoptotic cells showed that these influenza-specific CD8+ T cells from liver are as viable as those in the spleen, bronchoalveolar lavage, mediastinal lymph nodes, or lung. Moreover, cytokine profiles of the influenza-specific CD8+ T cells recovered from different sites were consistent with the bronchoalveolar lavage, rather than liver population, being the most susceptible to activation-induced cell death. Importantly, adoptively transferred influenza virus-specific CD8+ T cells from the liver survived and were readily recalled after virus challenge. Together, these results show clearly that the liver is not a "graveyard" for influenza virus-specific CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17312116     DOI: 10.4049/jimmunol.178.5.2737

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Up-regulation of LFA-1 allows liver-resident memory T cells to patrol and remain in the hepatic sinusoids.

Authors:  H A McNamara; Y Cai; M V Wagle; Y Sontani; C M Roots; L A Miosge; J H O'Connor; H J Sutton; V V Ganusov; W R Heath; P Bertolino; C G Goodnow; I A Parish; A Enders; I A Cockburn
Journal:  Sci Immunol       Date:  2017-03-17

2.  A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection.

Authors:  John A Mengshol; Lucy Golden-Mason; Tomohiro Arikawa; Maxwell Smith; Toshiro Niki; Ryan McWilliams; Jessica A Randall; Rachel McMahan; Michael A Zimmerman; Manu Rangachari; Evgenia Dobrinskikh; Pierre Busson; Stephen J Polyak; Mitsuomi Hirashima; Hugo R Rosen
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 3.  Living in the liver: hepatic infections.

Authors:  Ulrike Protzer; Mala K Maini; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

4.  Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy.

Authors:  Victoria M Velazquez; David G Bowen; Christopher M Walker
Journal:  Blood       Date:  2008-06-19       Impact factor: 22.113

5.  Liver is able to activate naïve CD8+ T cells with dysfunctional anti-viral activity in the murine system.

Authors:  John R Lukens; Joseph S Dolina; Taeg S Kim; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

6.  Screening monoclonal antibodies for cross-reactivity in the ferret model of influenza infection.

Authors:  John A Rutigliano; Peter C Doherty; John Franks; Melissa Y Morris; Cory Reynolds; Paul G Thomas
Journal:  J Immunol Methods       Date:  2008-04-28       Impact factor: 2.303

Review 7.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

8.  Mechanism of T cell tolerance induction by murine hepatic Kupffer cells.

Authors:  Qiang You; Linling Cheng; Ross M Kedl; Cynthia Ju
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

Review 9.  Malaria and the liver: immunological hide-and-seek or subversion of immunity from within?

Authors:  Patrick Bertolino; David G Bowen
Journal:  Front Microbiol       Date:  2015-02-18       Impact factor: 5.640

10.  A unified framework of immunological and epidemiological dynamics for the spread of viral infections in a simple network-based population.

Authors:  David M Vickers; Nathaniel D Osgood
Journal:  Theor Biol Med Model       Date:  2007-12-20       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.